Literature DB >> 16407380

To be or not to be--an incretin or enterogastrone?

M Horowitz1, M A Nauck.   

Abstract

Glucagon-like peptide 1 does not comfortably fulfil the criterion of a gut derived factor responsible for an enhanced meal related insulin response; it appears logical to add the definition of a "physiological incretin hormone".

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16407380      PMCID: PMC1856501          DOI: 10.1136/gut.2005.071787

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  30 in total

1.  Effect of variations in small intestinal glucose delivery on plasma glucose, insulin, and incretin hormones in healthy subjects and type 2 diabetes.

Authors:  Deirdre G O'Donovan; Selena Doran; Christine Feinle-Bisset; Karen L Jones; James H Meyer; Judith M Wishart; Howard A Morris; Michael Horowitz
Journal:  J Clin Endocrinol Metab       Date:  2004-07       Impact factor: 5.958

Review 2.  The incretin concept today.

Authors:  W Creutzfeldt
Journal:  Diabetologia       Date:  1979-02       Impact factor: 10.122

3.  Stimulation of insulin secretion by gastric inhibitory polypeptide in man.

Authors:  J Dupre; S A Ross; D Watson; J C Brown
Journal:  J Clin Endocrinol Metab       Date:  1973-11       Impact factor: 5.958

4.  Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.

Authors:  R Göke; H C Fehmann; T Linn; H Schmidt; M Krause; J Eng; B Göke
Journal:  J Biol Chem       Date:  1993-09-15       Impact factor: 5.157

5.  Effect of meal volume and energy density on the gastric emptying of carbohydrates.

Authors:  J N Hunt; J L Smith; C L Jiang
Journal:  Gastroenterology       Date:  1985-12       Impact factor: 22.682

Review 6.  The physiological role of GLP-1 in human: incretin, ileal brake or more?

Authors:  Jörg Schirra; Burkhard Göke
Journal:  Regul Pept       Date:  2005-06-15

Review 7.  Relationships of upper gastrointestinal motor and sensory function with glycemic control.

Authors:  C K Rayner; M Samsom; K L Jones; M Horowitz
Journal:  Diabetes Care       Date:  2001-02       Impact factor: 19.112

Review 8.  Biological actions and therapeutic potential of the glucagon-like peptides.

Authors:  Daniel J Drucker
Journal:  Gastroenterology       Date:  2002-02       Impact factor: 22.682

9.  Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).

Authors:  Louis Monnier; Hélène Lapinski; Claude Colette
Journal:  Diabetes Care       Date:  2003-03       Impact factor: 19.112

Review 10.  Gastric inhibitory polypeptide: the neglected incretin revisited.

Authors:  Juris J Meier; Michael A Nauck; Wolfgang E Schmidt; Baptist Gallwitz
Journal:  Regul Pept       Date:  2002-07-15
View more
  9 in total

Review 1.  Incretins and the development of type 2 diabetes.

Authors:  Juris J Meier; Michael A Nauck
Journal:  Curr Diab Rep       Date:  2006-06       Impact factor: 4.810

Review 2.  Peripheral neural targets in obesity.

Authors:  Amanda J Page; Erin Symonds; Madusha Peiris; L Ashley Blackshaw; Richard L Young
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

Review 3.  Upper gastrointestinal function and glycemic control in diabetes mellitus.

Authors:  Reawika Chaikomin; Christopher K Rayner; Karen-L Jones; Michael Horowitz
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

Review 4.  Effects of GLP-1 and incretin-based therapies on gastrointestinal motor function.

Authors:  Chinmay S Marathe; Christopher K Rayner; Karen L Jones; Michael Horowitz
Journal:  Exp Diabetes Res       Date:  2011-06-22

5.  Sensing via intestinal sweet taste pathways.

Authors:  Richard L Young
Journal:  Front Neurosci       Date:  2011-03-03       Impact factor: 4.677

6.  Exogenous glucose-dependent insulinotropic polypeptide worsens post prandial hyperglycemia in type 2 diabetes.

Authors:  Chee W Chia; Olga D Carlson; Wook Kim; Yu-Kyong Shin; Cornelia P Charles; Hee Seung Kim; Denise L Melvin; Josephine M Egan
Journal:  Diabetes       Date:  2009-03-10       Impact factor: 9.461

7.  The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study.

Authors:  Adam M Deane; Marianne J Chapman; Robert J L Fraser; Carly M Burgstad; Laura K Besanko; Michael Horowitz
Journal:  Crit Care       Date:  2009-05-13       Impact factor: 9.097

Review 8.  Relationships between gastric emptying, postprandial glycemia, and incretin hormones.

Authors:  Chinmay S Marathe; Christopher K Rayner; Karen L Jones; Michael Horowitz
Journal:  Diabetes Care       Date:  2013-05       Impact factor: 19.112

Review 9.  Sugars, Sweet Taste Receptors, and Brain Responses.

Authors:  Allen A Lee; Chung Owyang
Journal:  Nutrients       Date:  2017-06-24       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.